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Abstract
Retinoic Acid (RA) is a small lipophilic signaling molecule essential for embryonic development and adult tissue
maintenance. Both an excess of RA and a deficiency of RA can cause pathogenic anomalies, hence it is critical to understand
the mechanisms controlling the spatial and temporal distribution of RA. However, our current understanding of these
processes remains incomplete. Vitamin A is metabolized to RA via two sequential enzymatic reactions. The first requires
retinol dehydrogenase (RDH) activity to oxidize Vitamin A (retinol) to retinal, and the second requires retinaldehyde activity
(RALDH) to oxidize retinal into RA. The first reaction has previously been attributed to the alcohol dehydrogenase (ADH)
family, whose genes are ubiquitously or redundantly expressed. Consequently, the specificity of RA synthesis was thought
to reside exclusively at the level of the second reaction. To better understand the metabolism of Vitamin A into RA during
embryogenesis, we generated new mouse models that disrupt this process. Here we describe a new targeted knockout of
Rdh10 in which RA synthesis is severely impaired, particularly at critical early embryonic stages. We also introduce a new
mutant allele of Aldh1a2. Both mutations produce similar developmental defects resulting in lethality around embryonic day
10.5 (E10.5). The severity of the Rdh10 null phenotype demonstrates that embryonic oxidation of retinol is carried out
primarily by RDH10 and that neither ADHs nor other enzymes contribute significantly to this reaction. We also show that
reduced RA production results in upregulation of Rdh10. These data demonstrate that RDH10 plays a critical role in
mediating the rate limiting RDH step of Vitamin A metabolism and functions as a nodal point in feedback regulation of RA
synthesis. Moreover, RDH10-mediated oxidation of retinol plays as important a role in the control and regulation of RA
production during embryogenesis as does the subsequent RALDH-mediated reaction.
Citation: Sandell LL, Lynn ML, Inman KE, McDowell W, Trainor PA (2012) RDH10 Oxidation of Vitamin A Is a Critical Control Step in Synthesis of Retinoic Acid
during Mouse Embryogenesis. PLoS ONE 7(2): e30698. doi:10.1371/journal.pone.0030698
Editor: Domingos Henrique, Instituto de Medicina Molecular, Portugal
Received October 8, 2011; Accepted December 23, 2011; Published February 2, 2012
Copyright:  2012 Sandell et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Research in the Trainor laboratory is supported by the Stowers Institute for Medical Research and the National Institute of Dental and Craniofacial
Research (R01 DE 016082). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pat@stowers.org (PAT); lisa.sandell@louisville.edu (LLS)
Introduction
Retinoic acid (RA) is a derivative of Vitamin A (retinol) that
plays an essential role in many vertebrate biological processes
including energy metabolism, brain function, immune response,
reproduction and embryonic development (reviewed in [1,2,3,
4,5,6]). The processes of embryonic growth and patterning are
particularly dependent on this small molecule, as can be
appreciated by the striking abnormalities and midgestation
lethality that occur when RA metabolism is limited or disrupted
during development in mice [7,8,9,10] or other mammals
[11,12,13,14]. The defects arising from RA perturbation occur
because RA controls the transcription of a variety of essential
developmental genes by virtue of its function as a ligand that binds
to retinoic acid receptors (RAR). The RAR, which form
heterodimers with retinoid receptors (RXR), activate or repress
gene activity when RA is bound (reviewed in [15]). Owing to the
importance of RA in regulating essential developmental processes,
it is critical to understand the mechanisms that regulate the
metabolism of this key compound.
Unlike many signaling molecules whose function is modulated
by changes in RNA transcription or protein activity, RA is a small
molecule whose level and tissue distribution are regulated by
biochemical synthesis and by degradation. It has been known for
some time that synthesis of RA from the dietary precursor retinol
occurs via two sequential enzymatic reactions - first retinol is
oxidized to form retinal and, second, retinal is oxidized to form
RA [16]. The first reaction is facilitated by enzymes with retinol
dehydrogenase (RDH) activity and the second reaction is carried
out by enzymes with retinaldehyde dehydrogenase activity
(RALDH).
The RALDH second step of RA synthesis is carried out by
RALDH1, RALDH2 and RALDH3, which are encoded by
Aldh1a1, Aldh1a2 and Aldh1a3, respectively [7,8,9,10]. RALDH2 is
the primary enzyme responsible for conversion of retinal to RA
during early embryogenesis, mediating the major part of RA
synthesis within the early developing embryo [8]. Loss of
RALDH2 function eliminates RA signaling within the trunk
region and results in severe developmental abnormalities,
including shortened anteroposterior axis, defects in embryo
turning, dilated and un-looped hearts, small somites, absence of
forelimb buds and lethality by embryonic day 10.5 (E10.5). Loss of
RALDH3 disrupts RA signaling in the embryonic head, resulting
in defects in formation of the nose and eye and lethality at birth.
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clearly demonstrate the critical nature of the RALDH reaction in
embryonic RA synthesis.
In contrast to the well-established importance of the RALDH
second reaction, the RDH first reaction of RA synthesis has
received less attention due to the misperception that it occurs
ubiquitously throughout embryogenesis. Two types of molecule
are capable of RDH activity in vitro: members of the alcohol
dehydrogenase (ADH) family, which are cytosolic medium chain
reductases (MDR), and members of the RDH family, which are
membrane-bound short chain dehydrogenase/reductases (SDR)
(reviewed in [17]). ADH enzymes have the ability to catalyze the
conversion of retinol to retinal in vitro [18]. Owing to this
biochemical activity of ADH enzymes, together with an
overlapping or ubiquitous pattern of Adh gene expression during
embryogenesis [19], it was initially proposed that the embryonic
oxidation of retinol to retinal was carried out by ADH enzymes
within the cytosol [20,21,22]. However, despite their biochemical
activity and their widespread in vivo expression pattern, disruption
of single and compound Adh genes produced no embryonic defects
[21], a lack of effect that was speculatively attributed to potential
redundancy within the gene family. The failure to identify an Adh
mutant embryonic phenotype led to the prevailing view that the
first step of embryonic Vitamin A metabolism is mediated by
ubiquitous or redundant enzymes and plays a minimal role in the
spatiotemporal regulation of RA synthesis.
The notion that the initial oxidative conversion of retinol occurs
in an unregulated fashion mediated by ADHs has been challenged
by recent discoveries highlighting a critical role for the SDR
RDH10 in tissue specific synthesis of RA within the vertebrate
embryo. The first indication that RDH10 is important for
embryonic synthesis of RA came from characterization of mice
with a point mutation termed Rdh10
trex [23]. Embryos homozygous
for this mutation exhibit a dramatic reduction in RA synthesis and
severe defects in embryonic development including limb, cranio-
facial and organ defects that result in lethality between E10.5–
14.5. Further evidence of a role for RDH10 came from Xenopus,i n
which XRDH10 was shown to be critical for RA synthesis and to
be controlled by RA negative feedback inhibition [24]. In
zebrafish, the rdh10a gene was found to be subject to positive
and negative feedback regulation by RA, as was, inversely, dhrs3a,
whose product catalyzes the reverse reaction converting retinal
back into retinol [25]. In chick embryos, expression of Rdh10 is
regulated spatially and temporally in a pattern overlapping with
the retinol transporter Stra6, but does not appear to be regulated
by feedback from excessive or reduced levels of RA [26]. These
recent findings raise questions of the specific contribution of
RDH10 versus ADHs and of the true mechanistic importance of
the first oxidation step of Vitamin A metabolism in controlling
embryonic RA synthesis.
The embryonic abnormalities and RA reduction observed in
Rdh10
trex mutant mice are dramatic, but generally not as severe as
those caused by loss of RALDH2. Embryos lacking RALDH2 do
not survive past E10.5 [8,27], while most homozyogous Rdh10
trex
embryos remain viable through E10.5–E11.5 and embryos have
been identified surviving as late as E14.5 [23,28]. The residual
production of RA and the less severe phenotype of Rdh10
trex
embryos compared to Aldh1a2 mutant embryos indicate that some
RDH activity remains intact in the Rdh10
trex embryos, mediated
possibly by hypomorphic activity of the Rdh10
trex point mutant
enzyme, by other RDH enzymes, or by ADH enzymes. In order to
further our understanding of the regulation of RA synthesis during
embryonic development, it is important to know which enzymes
catalyze the RDH reaction and whether the relevant enzymes are
redundant and ubiquitous within the embryo or if they are instead
expressed in a regulated fashion that may have bearing on the
control of production of this important signaling molecule.
To clarify the enzymatic regulation of Vitamin A metabolism
and RA synthesis during embryogenesis, we have generated new
mouse models that disrupt this process and comprise a graded
series of RA deficiency. Here we describe a novel targeted
knockout allele of Rdh10. We show that eliminating RDH10
activity results in severe embryonic abnormalities, more extreme
than the phenotype of the original Rdh10
trex point mutant. In this
report we also introduce a new point mutant allele of Aldh1a2,
generated in a chemical mutagenesis screen, which disrupts the
RALDH reaction and exhibits a phenotype similar to previously
described targeted knockout alleles of Aldh1a2. Both the Rdh10
knockout embryos and the Aldh1a2 point mutant embryos exhibit
similar shortened anteroposterior axes, defects in embryo turning,
dilated and un-looped hearts, small somites, and forelimb bud
agenesis. Each results in embryo death by ,E10.5. Using the
RARElacZ reporter transgene, we show that RA synthesis in
Rdh10 null embryos is severely reduced at E9.5 and is almost
completely eliminated at the earlier critical E8.0–E8.5 stage of
development. The severity of the Rdh10 null phenotype indicates
that the RDH mediated oxidation of retinol to retinal during
Vitamin A metabolism is carried out primarily by RDH10 and
that neither ADH family members nor other enzymes contribute
significantly to the RDH step of RA synthesis during early
embryogenesis. In this report we also find that Rdh10 gene
expression is elevated when RA levels are reduced, providing
evidence that Rdh10 functions as a control point for feedback
regulation of the RA synthesis pathway in mammals. These data
demonstrate that the initial RDH reaction of Vitamin A
metabolism, mediated primarily by RDH10, plays as critical a
role in embryogenesis and is as important in the control and
regulation of RA production as is the subsequent RALDH
reaction.
Results
Graded retinoid deficiency phenotypes: Rdh10
trex vs.
Aldh1a2
gri
The previously reported mouse Rdh10
trex point mutation
disrupts RDH10 function and causes numerous embryonic defects
culminating in embryo death between E.10.5–14.5 [23]. In
Rdh10
trex/trex mutant embryos RA synthesis is reduced but not
completely eliminated, as residual RA signaling is detected in the
trunk neural tube. This raised the possibility that Rdh10
trex/trex may
be a severe hypomorph rather than a complete null. For
comparison with other mutants in the present study, we examined
Rdh10
trex/trex embryos at E9.5 and E10.5 (Fig. 1A,B,D,E). Although
the Rdh10
trex/trex phenotype is somewhat variable at E9.5, all
embryos have numerous discernible abnormalities. First and
second pharyngeal arches form in most Rdh10
trex/trex mutant
embryos, but third and more posterior pharyngeal arches are
absent or fused to the second arch (Fig. 1B,E). Otic vesicles are
usually small, duplicated and displaced posteriorly (Fig. 1B).
Mutant embryos exhibit cardiac abnormalities, including heart
edema and looping defects (Fig. 1B). At E10.5 a reduction in size
of the forelimb bud and absence of posterior pharyngeal arches are
clearly evident (Fig. 1E). This constellation of defects observed in
the Rdh10
trex/trex embryos is consistent with retinoid deficiency but
is less severe than that observed in embryos in which RALDH2
function has been eliminated.
As part of the same chemical mutagenesis screen that yielded
the Rdh10
trex mutation, we also generated a mutant originally
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formation of the pharyngeal arches (Fig. 1C). Mapping, cloning
and sequence analysis were used to identify the grimace mutation,
which was determined to be a single base change within the
Aldh1a2 locus. We therefore henceforth refer to this mutation as
Aldh1a2
gri. Sequence analysis of genomic DNA reveals that the
Aldh1a2
gri mutation alters the 59 splice consensus sequence at the
boundary of exon 4 and intron 4–5, changing the second intronic
nucleotide from a conserved T to a C (Fig. 1G). The altered splice
consensus sequence disrupts splicing of Aldh1a2 mRNA and leads
to a reduction in Aldh1a2 transcript level. Quantitative RT-PCR
reveals that Aldh1a2 transcript in homozygous Aldh1a2
gri/gri
mutants is reduced to less than 1% of that of wild type embryos
(Fig. 1H). We therefore interpret the new Aldh1a2
gri mutation is
either a null allele of Aldh1a2 or an extreme hypomorph.
Consistent with the loss of Aldh1a2 transcript, we observe the
Figure 1. Rdh10
trex and new Aldh1a2
gri mutant phenotype comparison. Wild type (A,D), Rdh10
trex/trex mutant (B,E), and Aldh1a2
gri/gri mutant
(C,F) embryos were collected at E9.5 (A–C) and E10.5 (D–F). Formalin-fixed embryos were stained with DAPI and imaged by confocal microscopy. For
each embryo, a Z-stack of confocal slices was collapsed to form a ‘‘pseudo-SEM’’ image. (A–F) For each mutant phenotype at each indicated stage
n.5 embryos. (G) Sequence of Aldh1a2 gene at junction between Exon 4 and Intron 4–5 with grimace mutation single base change indicated
beneath. Exon 4 genomic DNA sequence is indicated by yellow highlight, intron 4–5 sequence indicated by pink highlight. (H) Histogram
representing relative levels of Aldh1a2 mRNA from wild-type, heterozygous Aldh1a2
gri/+ and homozygous Aldh1a2
gri/gri embryos, as assessed by
quantitative RT-PCR, demonstrating loss of Aldh1a2 transcript in homozygous mutants. fl, forelimb bud; h, heart; ov, otic vesicle; ppa, posterior
pharyngeal arches.
doi:10.1371/journal.pone.0030698.g001
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gri/gri mutants to be very similar
to that of established Aldh1a2 knockout alleles, each exemplifying
the abnormalities associated with severe retinoid deficiency
(Fig. 1C,F). Mutant Aldh1a2
gri/gri embryos die by E10.5 exhibiting
a number of striking defects including cessation of growth at
,E8.5–E9.0, defects in axial turning, dilated unlooped hearts,
small somites and tiny otic vesicles. Whereas established knock
alleles of Aldh1a2 exhibit no axial turning, many Aldh1a2
gri/gri
mutants display a slightly milder phenotype with a small degree of
embryo turning. The slightly milder turning defect may represent
a difference of strain background on the axial turning phenotype
or may indicate that the Aldh1a2
gri allele is not an absolute null.
Comparison of the Rdh10
trex versus the Aldh1a2
gri phenotypes
illustrates the less extreme defects elicited by Rdh10
trex mutation
relative to that of Aldh1a2
gri (compare Fig. 1 E, F). At E9.5
Aldh1a2
gri/gri mutants have extreme defects in extension and
turning of the body axis, with some embryos completely unturned
and others with an abnormal half-turned ‘‘J’’ shaped body axis
when viewed from the front. In contrast, nearly all E9.5 Rdh10
trex/trex
embryos are completely turned. Aldh1a2
gri/gri mutant embryos lack
all pharyngeal arches posterior to the first arch, whereas many
Rdh10
trex/trex embryos form second arches and, in some cases,
rudimentary third arches. The milder phenotype of the Rdh10
trex/trex
embryos relative to the severe phenotype of Aldh1a2
2/2 mutants,
together with the presence of residual RA activity detected using
RARElacZ reporter mice [23], implies the presence of residual RDH
function within Rdh10
trex/trex embryos. The residual RA in these
embryos could result from a small amount of RDH activity
remaining for the mutant RDH10 protein, or to the function of
unidentified RDH or ADH enzymes.
Generation of Rdh10 knockout mice
In order to directly evaluate the contribution of RDH10 in
embryonic RA synthesis we sought to completely eliminate
RDH10 function from developing mouse embryos. To that end,
we generated mice null for RDH10 activity utilizing ES cells
produced by the Chori-Sanger-UC Davis (CSD) arm of the
international Knockout Mouse Project (KOMP) consortium. The
CSD KOMP knockout construct is designed to create a series of
alleles that can be generated by sequential deletion through
exposure to Cre or FLP recombinase (Fig. 2A). The initial targeted
knock-in construct inserts a splice acceptor-lacZ gene trap cassette
between exon 1 and exon 2 of the Rdh10 gene, an allele we call
Rdh10
bgeo. The gene trap insertion is expected to produce a null
allele by disrupting the endogenous Rdh10 transcript and
producing instead a reporter lacZ fusion transcript. Exposure of
the gene trap allele to FLP-recombinase can then be used to excise
the disruptive splice acceptor cassette (flanked by FRT sites). FLP-
mediated excision of the gene trap cassette creates a functionally
wild type/conditional knockout allele of Rdh10 with loxP sites
flanking exon 2, an allele we call Rdh10
flox. Cre-mediated
recombination can then be used to excise the loxP-flanked exon
2, thereby producing a null allele we call Rdh10
delta. Exon 2 was
chosen for deletion because its absence is predicted to create a
frameshift mutation thereby truncating any resulting protein
product and targeting the transcript for nonsense mediated decay.
Prior to distribution, correct targeting of the gene trap construct to
the Rdh10 genomic locus in ES cells was assessed by 59 and 39 PCR
junction fragment assays at the KOMP production and distribu-
tion centers. The quality control tests included long range PCR
assays pairing generic targeting cassette primers with Rdh10 locus-
specific genomic primers homologous to the sequences upstream
and downstream of the target site.
In order to generate mice bearing an Rdh10 knockout allele, we
obtained from the KOMP consortium ES cell clone Rdh10_D08,
which is heterozygous for the Rdh10 gene trap allele. These ES
cells were injected into C57BL6/J blastocysts to produce chimeric
mice that were identified by PCR amplification of the bgeo fusion
gene from tail DNA samples. Male mice chimeric for the Rdh10
gene trap allele were then mated to identify individual animals
transmitting the targeted allele. Mice carrying the Rdh10
bgeo gene
trap allele were crossed with mice carrying ubiquitously expressed
FLP recombinase [30] to generate a conditional Rdh10
flox allele.
Exposure of the gene trap allele to FLP recombinase resulted in
excision of the gene trap/bgeo portion of the targeting cassette and
leaving a pair of loxP sites flanking exon 2 to create the conditional
allele. Rdh10
flox mice were then crossed with mice bearing a female
germline expressed Cre recombinase [31]. The resulting exposure
Figure 2. Targeted Rdh10 gene trap and knockout allele. (A) Schematic diagram of Rdh10 knockout allele obtained as ES cells from KOMP
consortium and derivative alleles. For Rdh10
bgeo allele, a gene-trap splice acceptor bgeo cassette is introduced between exon 1 and exon 2 of Rdh10
and loxP sites are introduced surrounding exon 2. For the Rdh10
flox allele, the gene trap cassette is excised returning function, conditionally, to the
Rdh10 gene. For the Rdh10
delta allele, exon 2 is deleted by Cre excision of the DNA between the loxP sites. (B) Rdh10 RNA in situ hybridization of E9.5
wild type embryo reveals expression of Rdh10 in specific tissues. Rdh10 RNA staining pattern n.10 embryos. (C) Staining E9.5 Rdh10
bgeo embryofor b-
galactosidase activity (arrow) reveals gene trap transcript expressed in pattern similar to Rdh10 RNA expression. Rdh10 b-galactosidase staining
pattern n.10 embryos. ba, branchial arch; ht, heart; lb, limb bud; op, optic vesicle; psm, presomitic mesoderm; s, somite.
doi:10.1371/journal.pone.0030698.g002
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flox allele to Cre recombinase caused excision of the
loxP-flanked exon 2 thereby generating Rdh10
delta allele.
Embryos heterozygous for the Rdh10
bgeo gene trap alleles were
assessed for expression of the reporter bgeo transcript by staining
for b-galactosidase activity. In these embryos b-galactosidase
activity was very weak but the Rdh10
bgeo gene trap transcript could
be detected in a pattern similar to that of the endogenous Rdh10
transcript (Fig. 2 B–C). Both the endogenous Rdh10 mRNA,
detected by RNA in situ hybridization and the Rdh10
bgeo gene trap
reporter are present in the posterior pharyngeal region and the
lateral plate mesoderm between the fore- and hind-limb buds.
Expression of Rdh10 mRNA and the Rdh10
bgeo gene trap reporter
are also present in the isthmus of the midbrain and in the dorsal
somites. These sites correspond to the previously reported
expression domains for Rdh10 [23,32].
Rdh10 gene trap allele causes severe retinoid deficiency
phenotype
Animals heterozygous for the Rdh10
bgeo allele are viable and
fertile, with no overt abnormalities. Homozygous Rdh10
bgeo/bgeo
embryos, however, exhibit all the hallmarks of extreme retinoid
deficiency, with a phenotype remarkably similar to embryos
lacking Aldh1a2. At E9.5, Rdh10
bgeo/bgeo embryos display defects in
embryo growth and axial turning (Fig. 3A–B). Posterior pharyn-
geal arches are absent. Otic vesicles are present, but reduced in
size. Somites are small and extension of the body axis is impaired.
Hearts are unlooped and edemic. The parallels between the
Rdh10
bgeo/bgeo phenotype and phenotypes of Aldh1a2
2/2 mutants
indicate that RDH10 deficiency is as deleterious to embryonic
growth and patterning as is ALDH1A2 deficiency.
Mice carrying the Rdh10
bgeo allele were crossed with Rdh10
trex to
generate compound heterozygote Rdh10
bgeo/trex embryos. The
compound heterozygous embryos displayed a range of phenotypes
(Fig. 3 C–D). The most severely affected resembled Rdh10
bgeo/bgeo
embryos and the mildest were similar to Rdh10
trex/trex embryos.
Failure of the Rdh10
bgeo allele to complement the Rdh10
trex
mutation provides genetic confirmation that the Rdh10 conditional
construct is correctly targeted to the Rdh10 locus.
Rdh10 deletion allele causes severe retinoid deficiency
phenotype
Similar to the Rdh10
bgeo mice, animals heterozygous for the
Rdh10
delta mutation are also viable and fertile with no obvious
defects. Rdh10
delta/delta embryos can be recovered at the expected
Mendelian frequency at E9.5 and E10.5 but viable homozygous
embryos are not recovered at later stages (Rdh10
delta/delta genotype:
E9.5 n=12/47, E10.5 n=4/10, E11.75–E12.5 n=0/32). In the
homozygous state, the Rdh10
delta allele produces all the classic
hallmark phenotypes of severe retinoid deficiency (Fig. 4 A–D).
Rdh10
delta/delta mutants have defects in growth and axial turning.
Axial turning defects are most apparent at E9.5, when many
Rdh10
delta/delta embryos appear to be caught in an abnormal
leftward ‘‘J’’ shape or, occasionally, a rightward ‘‘L’’ body shape
when viewed from the front (Fig. 4 B). Some embryos have a
milder phenotype in which the tailbud is positioned in front of the
embryo, indicating that axial turning is complete. The growth
defect in Rdh10
delta/delta mutants is most obvious at E10.5. For wild
type embryos, overall embryo size increases substantially between
E9.5 and E10.5 (Fig. 4 A, C). Rdh10
delta/delta embryos, in contrast,
appear to cease growth and axis extension around E9.25.
Rdh10
delta/delta embryos have abnormalities in many tissues and
structures affected by retinoid deficiency including the heart, otic
vesicle, pharyngeal arches and forelimb buds. Cardiac defects are
observed in all Rdh10
delta/delta embryos. Hearts fail to undergo
normal looping and chamber formation, remaining, instead,
simple tubes oriented vertically and enlarged by edema. Otic
vesicles are present, but are tiny and occasionally duplicated.
Pharyngeal arch defects are also apparent in Rdh10
delta/delta
embryos. First arches are small and malformed, while arches
posterior to the first are absent altogether in most embryos.
Forelimb buds are reduced in size or absent.
The Rdh10
delta construct was designed to cause a null mutation
via deletion of exon 2, generating a stop codon that should disrupt
the open reading frame of the Rdh10 mRNA and target the
transcript for nonsense mediated decay. In order to verify that the
Rdh10
delta transcript encodes a premature stop codon, we
characterized Rdh10 cDNA from wild type and Rdh10
delta/delta
mutant embryos. The wild type Rdh10 mRNA encodes an open
reading frame that spans the 6 spliced exons of the transcript (Fig. 4
E). Amplification of Rdh10 cDNA from Rdh10
delta/delta embryos
produced a distinct product 235 bp shorter than the wild type
cDNA. Direct sequencing of the mutant Rdh10 cDNA revealed
that exon 2 is absent and exon 1 is spliced directly to exon 3,
producing a frame shift and generating a stop codon within the
open reading frame in the third codon of exon 3 (Fig. 4 E). Protein
produced from the Rdh10
delta transcript would be encoded by exon
1 only. Quantitative RT- PCR was performed to assess transcript
levels of the Rdh10
delta transcript. Transcript from Rdh10
delta/delta
embryos was detected at ,50% the level produced by wild type
embryos, suggesting that the Rdh10
delta transcript is targeted for
degradation by nonsense mediated decay (Fig. 4 F).
Loss of Rdh10 or Aldha2 reduces RA production
RDH10 and RALDH2 play sequential roles in synthesis of RA.
In order to assess the extent to which the new Rdh10
delta and
Aldh1a2
gri mutations disrupt RA synthesis, we utilized the RARE-
lacZ reporter transgene, which allows the level and distribution of
RA signaling to be visualized by staining for b-galactosidase
Figure 3. Phenotype of Rdh10
bgeo gene trap allele. (A) Wild type
and (B) homozygous Rdh10
bgeo/bgeo embryos were collected at E9.5
(Rdh10
bgeo/bgeo n=9). Wild type (C) and Rdh10
bgeo/trex compound
heterozygous (D) embryos were collected at E9.75 (n=6). Formalin-
fixed embryos were stained with DAPI and imaged by confocal
microscopy. For each embryo, a Z-stack of confocal slices was collapsed
to form a ‘‘pseudo-SEM’’ image.
doi:10.1371/journal.pone.0030698.g003
RDH10 Control of RA Synthesis
PLoS ONE | www.plosone.org 5 February 2012 | Volume 7 | Issue 2 | e30698Figure 4. Phenotype and characterization of transcript of Rdh10
delta allele. (A,C) Wild type and (B, D) homozygous Rdh10
delta/delta embryos
were collected at E9.5 (A–B) and E10.5 (C–D. (E9.5 mutant embryos n=34; rightward turn L complete n=33. E9.5 with leftward turn n=1. E10.5
mutant embryos n=5). Formalin-fixed embryos were stained with DAPI and imaged by confocal microscopy. For each embryo, a Z-stack of confocal
slices was collapsed to form a ‘‘pseudo-SEM’’ image. (E) Schematic diagram of Rdh10 spliced mRNA exon structure, along with coding sequence for
Rdh10 wild-type (full length) and Rdh10
delta mutant (truncated) as determined by direct sequencing of reverse transcribed Rdh10 mRNA. Yellow boxes
indicate spliced exons of Rdh10 mRNA. Dark blue arrow represent coding sequence of spliced wild type Rdh10 mRNA, blue boxes beneath arrow
symbolize truncated coding sequence resulting from splicing of exon 1 directly to exon 3. Nucleotide and protein sequence indicated beneath
schematic diagram shows 39 end of exon 1 spliced directly to 59 end of exon 3, generating a premature stop codon. Pink box indicates exon 1 derived
sequence, green box represents exon 3 derived sequence. (F) Histogram of elative level of Rdh10 mRNA as assessed by reverse transcription qPCR.
doi:10.1371/journal.pone.0030698.g004
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gri/gri mutant
embryos causes a severe reduction in RA signaling (Fig. 5 A–B), as
has been observed for previously reported knockout alleles of
Aldh1a2 [8,27]. Whereas wild type littermate embryos have strong
RA signaling throughout the trunk and within the forebrain,
homozygous Aldh1a2
gri/gri mutant embryos are almost completely
devoid of RA signaling. A small residual amount of RA signaling
can be detected in mutant embryos in the forebrain, consistent
with the RA signaling in previously reported alleles [8,27]. In the
mutants we examine here, there is also a very small amount of
residual RA signaling detected within the trunk, specifically within
the neural tube region at the level of the first few somites. These
data demonstrate that the Aldh1a2
gri mutation is either a null allele
or extreme hypomorph. The residual RA signaling observed
within the forebrain of mutant embryos corresponds to the signal
in previously reported knockout alleles of Raldh2 and likely results
from activity mediated by RALDH1 and RALDH3. The small
amount of RA signaling detected in the trunk of Aldh1a2
gri/gri
mutant embryos, which has also been observed in one of the
established Aldh1a2 knockout alleles [34], may result from a tiny
fraction of wild type activity remaining in the Aldh1a2
gri allele or
from variation in the null phenotype on different strain
backgrounds.
Analogous to the RA attenuation resulting from disruption of
Aldh1a2, loss of RDH10 function in the Rdh10
delta/delta mutants
also elicits a dramatic reduction in RA signaling (Fig. 5 C–J). At
E8.5 RA signaling in mutant embryos is essentially absent (Fig. 5
C–F). At E9.5 residual RA signaling can be detected in Rdh10
delta/delta
embryos within the trunk neural tube region, the extent and pattern
beingslightlybroaderthanisseenfortheAldh1a2
gri/gri mutants(Fig.5
G–J). Residual RA signaling within the forebrain, which is observed
in Aldh1a2
gri/gri mutants, is completely abolished in Rdh10
delta/delta
embryos. For the Rdh10
delta/delta mutant embryos, as with the
Rdh10
trex/trex mutant embryos, the residual RA signaling in the trunk
region is localized to the neural tube. Rdh10
delta/delta embryos also
retain a small amount of residual signaling in the heart and tissue
dorsal to the heart. Rdh10
delta/delta embryos have variable residual RA
signaling that is somewhat reflective of their variability in phenotype.
These data indicate that, at the critical E8.0–E8.5 stage of
development, RDH10 is essential for nearly all RDH activity within
the early developing embryo. At E9.5 and later stages, the residual
RA detected indicates that other enzymes can contribute a small
amount of RDH activity to metabolism of Vitamin A into RA and
the small amount of RA produced results in signaling concentrated
within the trunk neural tube.
Rdh10 transcription is upregulated by retinoid deficiency
The severe phenotype of the Rdh10
bgeo/bgeo and Rdh10
delta/delta
mutants and dramatic reduction in RA synthesis, indicate that
RDH10 is responsible for most RDH activity within the early
embryo and raises the possibility that the RDH reaction could
function as a control point in converting Vitamin A to RA. We
therefore sought to determine if embryo RA levels feed back to
regulate transcription of the Rdh10 gene. To that end we
evaluated Rdh10 expression in Aldh1a2
gri/gri mutant embryos in
which RA production is severely limited. Rdh10 expression levels
were assessed by quantitative RT-PCR of E9.5 Aldh1a2
gri/gri
mutant embryos and their wild type and heterozygous littermates
(Fig. 6 A). The RA deficient Aldh1a2
gri/gri embryos have
significantly elevated Rdh10 expression levels relative to wild
type embryos, with expression levels in homozygous mutant
embryos ranging between 1.3-fold and 1.8-fold higher than wild
type and heterozygous littermates. The elevated Rdh10 transcript
in Aldh1a2
gri/gri mutant embryos was expressed in the normal
spatial distribution within the embryo at E8.5 (Fig. 6B). These
data showing elevation of Rdh10 expression in RA-deficient
Aldh1a2
gri/gri mutant embryos clearly demonstrate that Rdh10
transcription is regulated by feedback from the metabolic product
RA in mice. Interestingly, Rdh10 contains a potential RAR-RXR
(RARE) sequence within exon 5, however to date it is not known
whether this is a functional motif nor if it acts in a negative or
positive fashion in response to retinoid signaling as has been
observed for other RAREs. Nonetheless, our results provide
compelling evidence that the RDH reaction is an important
control point in regulating metabolism of Vitamin A into RA in
mammals and sets the stage for future examination of the
complexities of feedback and feedforward enzymatic regulation
during this process.
Figure 5. Distribution of RA signaling in Rdh10 and Aldh1a2
mutant embryos. Embryos carrying the RARE-lacZ reporter transgene
were collected at E8.5, E9.5 or E10.5 and stained for b-galactosidase
activity to visualize RA signaling. Blue staining indicates presence of RA.
(A–B) Aldh1a2
gri/gri and littermates at E10.5. Arrow indicates small
amount of RA signaling detected in neural tube of mutant embryos,
n=13. (C–F) Rdh10
delta/delta and littermates at E8.5, n=5. (G–J)
Rdh10
delta/delta and littermate embryo at E9.5, n=6. Embryos shown in
lateral (G–H) or dorsal (I–J) view.
doi:10.1371/journal.pone.0030698.g005
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Importance of RDH reaction in RA production
Vertebrate embryonic development depends upon precise
spatial and temporal control of RA signaling. Two sequential
enzymatic steps are required for metabolism of retinol into RA,
the RDH first reaction and the RALDH second reaction (Fig. 6C).
Biochemically, either step could function as a control point for
regulating synthesis of RA. However, because the RDH first
reaction was initially attributed to ubiquitous or redundant
members of the ADH family and was thought to occur in an
unregulated fashion, the initial step of Vitamin A metabolism was
interpreted as being unimportant for the control of RA synthesis.
Over time this led to acceptance of the view that that control of
Vitamin A metabolism and RA synthesis was driven predomi-
nantly by the RALDH second step.
Figure 6. Rdh10 is up-regulated by reduction of RA. (A) Histogram representing relative levels of Rdh10 mRNA from wild type, heterozygous
Aldh1a2
gri/+ and homozygous Aldh1a2
gri/gri embryos, as assessed by quantitative RT-PCR, demonstrating elevated levels of Rdh10 transcript in
homozygous Aldh1a2
gri/gri mutants. (B) RNA in situ hybridization for expression of Rdh10 mRNA in E8.5 wild type and Aldh1a2
gri/gri mutant embryos,
demonstrating that the increased Rdh10 expression occurs in a pattern similar to the normal expression pattern for the gene (mutant embryos n=5).
(C) Model depicting that metabolic product RA feeds-back to reduce expression of membrane bound Rdh10 in mouse embryos. Pink lines represent
that RDH10 and RDH reaction occur in membrane-bound compartment. Cytosolic ADH enzymes do not contribute to any physiologically relevant
production of RA in the embryo.
doi:10.1371/journal.pone.0030698.g006
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unregulated fashion was challenged by the identification of
Rdh10
trex, a mutation that dramatically impairs RA synthesis via
disruption of RDH10, a spatially and temporally regulated
membrane-bound SDR. However, because the RDH reaction
had previously been thought to be carried out by redundant or
ubiquitous ADH family members, and because the Rdh10
trex
mutant embryos exhibited a milder phenotype and survived longer
than embryos lacking Aldha2, the RDH first reaction continued to
be thought of as relatively unimportant for the spatiotemporal
control of RA synthesis. The residual production of RA and the
less severe phenotype of Rdh10
trex embryos compared to Aldh1a2
mutant embryos indicated that some RDH activity remained
intact in the Rdh10
trex embryos, mediated possibly by remaining
activity of the hypomorphic Rdh10
trex point mutant enzyme, or by
other RDH enzymes, or by ADH enzymes. Given that genetic or
environmental perturbations causing excessive or insufficient levels
of RA cause embryonic malformations, it is important to resolve
the question of which enzymes catalyze the RDH reaction during
embryogenesis and, further, to understand whether these enzymes
function redundantly and ubiquitously or if their regulated
expression may serve as a control point for production of RA.
To gain insight into the enzymes and regulation of RA
synthesis, we have generated a knockout mutation of Rdh10 and
demonstrate that complete loss of the RDH10 enzyme results in
embryonic death ,E10.5. Rdh10
delta/delta embryos have severe
defects in growth, axial turning, and cardiac and pharyngeal
development. The severe embryonic phenotypes of Rdh10
delta/delta
mutants unequivocally demonstrate that redundant or ubiquitous
enzymes, including the members of the ADH family, do not
contribute significantly to physiologically relevant production of
RA during embryogenesis. Moreover, the severity of the
phenotypes resulting from loss of an individual enzyme,
RDH10, provides clear proof that the first RDH reaction of
Vitamin A metabolism is as critical a control point in the synthesis
of RA as the second RALDH reaction.
Although the phenotype of Rdh10
delta/delta mutant embryos is
very severe, it is not identical to the extreme phenotype of loss of
Aldha2. Loss of RALDH2 function results in embryos that
apparently cease to grow at by E8.5, whereas loss of Rdh10 results
in embryos that apparently cease to grow at around E9.0. The
slightly milder phenotype of the Rdh10
delta/delta embryos is likely due
to the small amount of residual RA produced at E9.5 within the
trunk region of affected embryos. The identity of the enzymes
responsible for the residual trunk RA at E9.5 is unknown. It is
possiblethesmallamountofresidual RA productioninRdh10
delta/delta
mutant embryos represents the contribution of other, as yet
unidentified, SDR enzymes closely related to RDH10 or, alterna-
tively, ADH enzymes. Recently, we demonstrated that a compound
knockout of multiple Adh genes does not impair the residual RA
synthesis in Rdh10
trex embryos nor exacerbate the phenotype [35], a
resultwhichargues againsta rolefor ADHs. Whichever enzymes are
ultimately found to be responsible for the small amount of residual
RA, it is clear that they are insufficient to produce physiologically
relevant levels of RAand areunableto compensate for lossofRdh10.
Concurrent with the present study, a distinct knockout allele of
Rdh10, a deletion of Rdh10 exon 4, was reported in the literature
[36]. The phenotypes of the Rdh10 exon 4 deletion allele (Rdh10
2/2)
are largely consistent with the Rdh10
delta allele we describe here.
In both cases, the majority of embryos survive until ,E10.5 and
exhibit defects in growth and extension of the body axis,
absence of posterior pharyngeal arches, compacted somites, and
small or duplicated otic vesicles. RA signaling is also notably
absent from the forebrain region in both knockout models at this
stage. The primary difference is that we do not observe embryo
survival beyond E10.5 in our Rdh10
delta mutants, whereas a small
fraction (,10%) of exon 4 deletion mutants survive until E12.5.
This difference may be related to variation in strain background
or the relative importance of the individual exons for Rdh10
activity that were deleted. We also examined RA signaling in
Rdh10
delta/delta embryos in a broader range of embryos and
observe that between the 1–6 somite stages (Fig. 5C–F), RA
signaling is not detected in Rdh10
delta/delta embryos compared to
the robust detection of reporter activity in control embryos.
Taken together, these data indicate the important role of Rdh10
in RA signaling during the early critical E8.0–8.5 window of
development.
Feedback regulation on RA metabolism
In addition to showing that RDH10 is the predominant enzyme
responsible for embryonic conversion of retinol to retinal, the data
presented here reveal that Rdh10 gene expression is modulated by
presence or absence of RA, being upregulated by RA deficiency in
Aldha2
gri/gri mutants. The upregulation of Rdh10 expression when
RA synthesis is impaired demonstrates that Rdh10 is a point for
feedback control in Vitamin A metabolism and RA synthesis in
mammals (Fig. 6C). A similar mode of regulation has been
observed in Xenopus and zebrafish, indicating that the mechanistic
feedback control of Rdh10 to modulate the RA synthesis pathway
is evolutionarily conserved [24,25]. The evolutionary conservation
of feedback regulation of the Rdh10 gene by RA lends further
support to the concept that RDH10-mediated oxidation of retinol
to retinal plays an important role in regulating the key process of
embryonic Vitamin A metabolism and RA synthesis.
The conversion of retinol to retinal is a reversible reaction.
Enzymes of the SDR family can mediate both the forward and the
reverse directions. Transcriptional regulation of SDR enzymes to
mediate RA homeostasis is observed in other contexts. In zebrafish
embryos, excess RA induces expression of dhrs3a, an SDR that
catalyzes the reduction of retinal into retinol [25]. In adult mouse
liver, chronic exposure to ethanol causes complex changes in RA
metabolism and is associated with transcriptional changes in RA
metabolic genes including induction of the SDR Dhrs9 [37].
Together these data suggest that reversible interconversion of
retinol to retinal by SDRs serve as a key control step in RA
homeostasis. Consistent with this, biochemical analysis of Vitamin
A metabolism in embryos has indicated that the first enzymatic
reaction, the oxidation of retinol to retinal, is the rate-limiting step
in the synthesis of retinoic acid [38].
Spatial localization of RA production in tissue and cell
The finding that the RDH reaction, mediated primarily by
RDH10, is a major control point in RA synthesis has implications
for understanding the tissue specificity and sub-cellular localization
of the sequential steps of RA production. With respect to tissue
distribution of Vitamin A metabolism and RA synthesis, it is
notable that the expression pattern of Rdh10 within an embryo is
very similar to, but not identical to that of Aldh1a2 [23,32]. In
chick, the expression pattern of Rdh10 has also been shown to
overlap with that of the gene encoding the retinol transporter Stra6
[26]. Together, these data suggest that retinol is imported into
cells, oxidized into retinal and subsequently into the product RA
all largely within the same population of cells. We have previously
shown that maternal administration of intermediate retinal, which
exposes all cells of the embryo to the retinal intermediate, can
rescue RDH10 deficient embryos to birth [39] and recently this
has now been extended postnataly [36]. Although viable, these
rescued embryos still exhibit some abnormalities including limb
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animals indicate that while embryo viability is not dependent on
spatially restricted retinal production, proper tissue patterning and
development are.
With respect to sub-cellular localization of Vitamin A
metabolism, the medium chain reductase ADH enzymes are
known to function within the cytosol, while the SDR RDHs
function in a membrane bound capacity. RDH10 is associated
with the membrane-bound compartment [40] and its membrane
association is necessary for its function [41]. Recently, we
demonstrated that the RDH reaction occurs not in the cytosol
where ADHs reside, but in a membrane-bound cellular compart-
ment such as that occupied by RDH10 [39]. Within the cytosol,
RBP1 binds to retinol and inhibits oxidation. The membrane
localization of RDH10 is functionally important, presumably
because it allows RDH10 to oxidize RBP1-free pools of retinol
available in the membrane compartment (Fig. 6C). These findings
suggest that ADHs do not contribute significantly to retinol
oxidation because they cannot oxidize the RBP1-bound retinol in
the cytosol and are unable to access RBP1-free retinol from
membranes (Fig. 6C). They explain why the cytosolic ADHs,
although widely expressed, cannot compensate for the loss of
RDH10 during embryogenesis.
The lack of function of ADHs in embryonic retinol oxidation is
consistent with studies of individual and compound Adh knockout
mice, which suggest that ADHs function primarily in governing
post-natal retinoid homeostasis (reviewed in [35]). In adult mice,
ADH1 provides considerable protection against vitamin A toxicity
[42,43] whereas ADH4 promotes survival during vitamin A
deficiency [44], a difference which illustrates distinct physiological
functions for these two enzymes in retinol metabolism. In contrast,
ADH3 appears to function redundantly in both the prevention of
retinol toxicity and Vitamin A deficiency, a dual role consistent
with its ubiquitous expression. Collectively, these biochemical and
compound mutant analyses strongly argue against a significant
role for ADHs in Vitamin A metabolism and RA synthesis during
embryonic development.
Given that Rdh10 is the predominant enzyme oxidizing retinol
to retinal and the mounting evidence that ADHs make little if any
contribution, we conclude that the conversion of retinol to retinal
within an embryo must occur predominantly, if not completely,
within a membrane-bound compartment. Collectively these data
demonstrate the critical roles played by Rdh10 in mediating
Vitamin A metabolism and synthesis of RA and as a nodal point in
governing the feedback regulation of RA production. Considering
the relatively discrete sites of Rdh10 expression, the allelic series of
Rdh10 alleles including conditional alleles described here, will
facilitate important strategies to characterize the consequences of
impaired Vitamin A metabolism and RA synthesis in a precisely
controlled spatiotemporal manner.
Materials and Methods
Generation of Rdh10 conditional mice
The Rdh10 mouse strains used for this research project were
generated from ES cells obtained from the trans-NIH Knockout
Mouse Project (KOMP) Repository, a NCRR-NIH supported
strain repository. ES cells were created by CSD consortium from
funds provided by the KOMP. To inquire about KOMP products
go to www.komp.org, email: or email service@komp.org. The
Rdh10_D08 (full clone name, EPD0149_1_D08) ES cell clone was
produced by the CSD consortium (Childrens Hospital of Oakland
Research Institute, The Sanger Institute, and UC Davis). Quality
control for correct targeting was assessed by the KOMP
production and distribution centers using PCR based assays that
spanned the 59 and 39 junction fragments. The parental ES cell
line was JM8.N4, which is a C57BL/6N background. For the mice
described in this report, we obtained Rdh10_D08 ES cells from
KOMP and injected them into C57BL/6 blastocysts. The Rdh10
gene trap line was thereby established and subsequently
maintained on a C57BL6/J background. Some animals, such as
those crossed with transgenic reporter lines, were mixed with other
backgrounds. The KOMP repository independently generated
mice from the same clone of ES cells. The strain name for the
KOMP generated mice is C57BL/6N-Rdh10
tm1a(KOMP)Wtsi.
Aldh1a2
gri mutant mice were originally described as grimace
mutants obtained as part of a chemical mutagenesis screen for
defects in early craniofacial development [29]. Mice carrying the
FLP recombinase (FLPeR) in the Rosa26 locus on a C57BL6
background [30] available from the Jackson Laboratory as stock
#009086 B6.129S4-Gt(ROSA)26Sor
tm1(FLP1)Dym/RainJ. Mice car-
rying a Cre recombinase transgene expressed in oocytes driven by
ZP3 promoter sequences [45] are available from the Jackson
Laboratory as stock #003651 C57BL/6-TgN(Zp3-Cre)93Knw.
Genotyping
All genotyping was accomplished by real-time PCR assays
performed by the commercial genotyping service Transnetyx
(Transnetyx.com). For the wild type Rdh10 allele assay, a probe
denoted ‘‘Rdh10-1 WT’’ was used to detect a fragment spanning
the region of the unmodified genomic locus corresponding to the
insertion site of the knock in construct. For the Rdh10
bgeo allele, an
assay was used to detect the presence of lacZ and neomycin,
corresponding to the bgeo cassette. For the Rdh10
delta allele, a probe
denoted ‘‘Rdh10-1EX’’ was used, which detects an amplified
region spanning the junction fragment covering the single
recombined FRT site and the 39 loxP site. To test for
homozygosity of the null allele, samples were screened for absence
of Rdh10 exon 2 using an assay probe designated ‘‘Rdh10-2 WT’’.
The following sequences indicate the relevant amplified regions,
excluding primers:
Rdh10 wild type allele
GCTCATTCATTGCTTGGCTTTGAATGAGTTTAGAT-
TGTTGCTTACAGTTTGGATTTGTGAGCCTTAAAGTGAA-
TTTC
Rdh10
delta allele
AGTTCCTATTCCGAAGTTCCTATTCTCTAGAAAGTA-
TAGGAACTTCGTCGAGATAACTTCGTATAGCATACATT-
ATACGAAGTTATGGTCTGAGCTCGCC
qPCR
To assay for Aldh1a2 expression in Aldh1a2
gri mutant embryos,
qRT-PCR TaqMan assay was used with the following probe and
primers:
Aldh1a2Fwd-TGA TAA AAT TCA CGG ATT GAC CAT
Aldh1a2Rev-GGG CTC GTG TCT TGT GAA AGT AA
Aldh1a2TaqMan Probe - CCTGTAGATGGAGACTAT
To assay for Rdh10 expression in wild type and Aldh1a2
gri
mutant embryos, qRT-PCR SYBR assay was used with the
following primers:
Rdh10-F: TGG TGT GGT TTC TGG ACA TCA CCT
Rdh10-R: CTC TAG CAT CGT TGG AAG AAA GGC
To assay for altered Rdh10 mRNA in Rdh10
delta mutant
embryos, qRT-PCR SYBR assay was used with the following
primers:
Rdh_q1F: CTGGGACTGTTCAGCACTG
Rdh_q1R: TCTACAAGGTAAGGGCAAACC
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whole mouse embryos
Whole mount in situ hybridization for Rdh10 was performed as
in [23]. Embryo morphology was visualized by staining whole
embryos with DAPI to label all cell nuclei and imaging fluorescent
signal. Embryos were fixed in 4% formalin overnight at 4uC then
stained with 2 ug/ml DAPI in PBS and imaged by confocal
microscopy using an LSM5 Pascal confocal microscope. For each
embryo, a Z-stack of confocal slices was collapsed to form a
‘‘pseudo-SEM’’ image. RA signaling was visualized by staining
embryos carrying the RARE-lacZ transgene for b-galactosidase
activity. A subset of the brightfield embryo images (Fig. 2D, Fig. 5
G–J, 6B) were processed with Helicon Focus image processing
software to compile and render the focused regions of multiple
focal planes as a single in-focus image. A minimum of 5 embryos
were used for each parameter analysed unless otherwise stated.
Web addresses for reagents and technique resources
Transnetyx automated qPCR genotyping: www.Transnetyx.
com
Knockout Mouse Project: www.KOMP.org
Rdh10 conditional knockout vector: http://www.sanger.ac.uk/
htgt/report/project_gene_report?project_id=34040
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